Maternal exposure to the CB1 cannabinoid agonist WIN 55212-2 produces robust changes in motor function and intrinsic electrophysiological properties of cerebellar Purkinje neurons in rat offspring

Neuroscience

Volumn 172, Issue , 2011, Pages 139-152

  Shabani, M ^a,b   Hosseinmardi, N ^a   Haghani, M ^a   Shaibani, V ^b   Janahmadi, M ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cannabinoids; Cerebellum; Intrinsic excitability; Prenatal exposure; Purkinje neurone; Whole cell patch

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; CANNABINOID; ION CHANNEL;

ACTION POTENTIAL; AFTERHYPERPOLARIZATION; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL POPULATION; CEREBELLUM; CONTROLLED STUDY; ELECTRIC POTENTIAL; ELECTROPHYSIOLOGY; ENVIRONMENTAL EXPOSURE; FEMALE; MALE; MOTOR PERFORMANCE; NERVE CELL EXCITABILITY; NEUROTRANSMISSION; NONHUMAN; OPEN FIELD TEST; PATCH CLAMP; PRIORITY JOURNAL; PURKINJE CELL; RAT; RIGHTING REFLEX; SYNAPTIC TRANSMISSION;

ANIMALS; BEHAVIOR, ANIMAL; BENZOXAZINES; CALCIUM CHANNEL BLOCKERS; CELL MEMBRANE; CEREBELLUM; DISEASE MODELS, ANIMAL; DYSKINESIA, DRUG-INDUCED; ENDOCANNABINOIDS; FEMALE; MALE; MORPHOLINES; MOTOR ACTIVITY; MOTOR SKILLS; NAPHTHALENES; ORGAN CULTURE TECHNIQUES; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; PURKINJE CELLS; RATS; RATS, WISTAR; RECEPTOR, CANNABINOID, CB1; SYNAPTIC TRANSMISSION; TIME FACTORS;

EID: 78650726739     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2010.10.031     Document Type: Article

References (88)

1. Abood M.E., Martin B.R. Neurobiology of marijuana abuse. Trends Pharmacol Sci 1992, 13:201-206.
2. Accorsi-Mendonca D., Almado C.E., Dagostin A.L., Machado B.H., Leao R.M. Inhibition of spontaneous neurotransmission in the nucleus of solitary tract of the rat by the cannabinoid agonist WIN 552122 is not via CB1 or CB2 receptors. Brain Res 2008, 1200:1-9.
3. Alviña K., Ellis-Davies G., Khodakhah K. T-type calcium channels mediate rebound firing in intact deep cerebellar neurons. Neuroscience 2009, 158:635-641.
4. Ameri A. The effects of cannabinoids on the brain. Prog Neurobiol 1999, 58:315-348.
5. Antonelli T., Tomasini M.C., Tattoli M., Cassano T., Tanganelli S., Finetti S., Mazzoni E., Trabace L., Steardo L., Cuomo V., Ferraro L. Prenatal exposure to the CB1 receptor agonist WIN 55,2122 causes learning disruption associated with impaired cortical NMDA receptor function and emotional reactivity changes in rat offspring. Cereb Cortex 2005, 15:2013-2020.
6. Bean B.P. The action potential in mammalian central neurons. Nat Rev Neurosci 2007, 8:451-465.
7. Beck H., Yaari Y. Plasticity of intrinsic neuronal properties in CNS disorders. Nat Rev Neurosci 2008, 9:357-369.
8. Bushnell P.J., Moser V.C., MacPhail R.C., Oshiro W.M., Derr-Yellin E.C., Phillips P.M., Kodavanti P.R. Neurobehavioral assessments of rats perinatally exposed to a commercial mixture of polychlorinated biphenyls. Toxicol Sci 2002, 68:109-120.
9. Callaway J.C., Ross W.N. Spatial distribution of synaptically activated sodium concentration changes in cerebellar Purkinje neurons. J Neurophysiol 1997, 77:145-152.
10. Campbell D.B., North J.B., Hess E.J. Tottering mouse motor dysfunction is abolished on the Purkinje cell degeneration (pcd) mutant background. Exp Neurol 1999, 160:268-278.
11. D'Angelo E., De Filippi G., Rossi P., Taglietti V. Ionic mechanism of electroresponsiveness in cerebellar granule cells implicates the action of a persistent sodium current. J Neurophysiol 1998, 80:493-503.
12. Deadwyler S.A., Hampson R.E., Mu J., Whyte A., Childers S. Cannabinoids modulate voltage sensitive potassium A-current in hippocampal neurons via a cAMP-dependent process. J Pharmacol Exp Ther 1995, 273:734-743.
13. Dowie M.J., Bradshaw H.B., Howard M.L., Nicholson L.F., Faull R.L., Hannan A.J., Glass M. Altered CB1 receptor and endocannabinoid levels precede motor symptom onset in a transgenic mouse model of Huntington's disease. Neuroscience 2009, 163:456-465.
14. Drews E., Schneider M., Koch M. Effects of the cannabinoid receptor agonist win 55,2122 on operant behavior and locomotor activity in rats. Pharmacol Biochem Behav 2005, 80:145-150.
15. Empson R.M., Turner P.R., Nagaraja R.Y., Beesley P.W., Knöpfel T. Reduced expression of the Ca(2+) transporter protein PMCA2 slows Ca(2+) dynamics in mouse cerebellar Purkinje neurons and alters the precision of motor coordination. J Physiol 2010, 588(Pt 6):907-922.
16. Fergusson D.M., Horwood L.J., Swain-Campbell N. Cannabis use and psychosocial adjustment in adolescence and young adulthood. Addiction 2002, 97:1123-1135.
17. Fernandes M., Kluwe S., Coper H. Cannabinoids and hexobarbital induced loss of righting reflexes. Naunyn Schmiedebergs Arch Pharmacol 1974, 283:431-435.
18. Ferraro L., Tomasini M.C., Beggiato S., Gaetani S., Cassano T., Cuomo V., Amoroso S., Tanganelli S., Antonelli T. Short- and long-term consequences of prenatal exposure to the cannabinoid agonist WIN55,2122 on rat glutamate transmission and cognitive functions. J Neural Transm 2009, 116:1017-1027.
19. Ferraro L., Tomasini M.C., Gessa G.L., Bebe B.W., Tanganelli S., Antonelli T. The cannabinoid receptor agonist WIN 55,212-2 regulates glutamate transmission in rat cerebral cortex: an in vivo and in vitro study. Cereb Cortex 2001, 11:728-733.
20. Fisyunov A., Tsintsadze V., Min R., Burnashev N., Lozovaya N. Cannabinoids modulate the P-type high-voltage-activated calcium currents in Purkinje neurons. J Neurophysiol 2006, 96:1267-1277.
21. Forney R.B. Toxicology of marihuana. Pharmacol Rev 1971, 23:279-284.
22. Fried P.A., Watkinson B., Gray R. A follow-up study of attentional behavior in 6-year-old children exposed prenatally to marihuana, cigarettes, and alcohol. Neurotoxicol Teratol 1992, 14:299-311.
23. A, receptor agonists in adult rats. Neurotoxicol Teratol 1999, 21:277-283.
24. Gerdeman G., Lovinger D.M. CB1 cannabinoid receptor inhibits synaptic release of glutamate in rat dorsolateral striatum. J Neurophysiol 2001, 85:468-471.
25. Goldschmidt L., Day N.L., Richardson G.A. Effects of prenatal marijuana exposure on child behavior problems at age 10. Neurotoxicol Teratol 2000, 22:325-336.
26. Goonawardena AV, Riedel G, Hampson RE (in press) Cannabinoids alter spontaneous firing, bursting, and cell synchrony of hippocampal principal cells. Hippocampus, in press.
27. Goudarzi I., Kaffashian M.R., Shabani M., Haghdoost-Yazdi H., Behzadi G., Janahmadi M. In vivo 4-aminopyridine treatment alters the neurotoxin 3-acetylpyridine-induced plastic changes in intrinsic electrophysiological properties of rat cerebellar Purkinje neurons. Eur J Pharmacol 2010, 642(1-3):56-65.
28. Haghdoust H., Janahmadi M., Behzadi G. Physiological role of dendrotoxin-sensitive K+ channels in the rat cerebellar Purkinje neurons. Physiol Res 2007, 56:807-813.
29. Häusser M., Clark B.A. Tonic synaptic inhibition modulates neuronal output pattern and spatiotemporal synaptic integration. Neuron 1997, 19:665-678.
30. Henry D.J., Chavkin C. Activation of inwardly rectifying potassium channels (GIRK1) by co-expressed rat brain cannabinoid receptors in Xenopus oocytes. Neurosci Lett 1995, 186:91-94.
31. Herkenham M., Groen B.G.S., Lynn A.B., DeCosta B.R., Richfield E.K. Neuronal localization of cannabinoid receptors and second messengers in mutant mouse cerebellum. Brain Res 1991, 552:301-310.
32. Hess D., El Manira A. Characterization of a high-voltage-activated IA current with a role in spike timing and locomotor pattern generation. Proc Natl Acad Sci U S A 2001, 98:5276-5281.
33. Howlett A.C. Pharmacology of cannabinoid receptors. Annu Rev Pharmacol Toxicol 1995, 35:607-634.
34. Huizink A.C., Mulder E.J. Maternal smoking, drinking or cannabis use during pregnancy and neurobehavioral and cognitive functioning in human offspring. Neurosci Biobehav Rev 2006, 30:24-41.
35. Irving A.J., Rae M.G., Coutts A.A. Cannabinoids on the brain. ScientificWorldJournal 2002, 2:632-648.
36. Iwasaki S., Chihara Y., Komuta Y., Ito K., Sahara Y. Low-voltage-activated potassium channels underlie the regulation of intrinsic firing properties of rat vestibular ganglion cells. J Neurophysiol 2008, 100:2192-2204.
37. Jaeger D., De Schutter E., Bower J.M. The role of synaptic and voltage-gated currents in the control of Purkinje cell spiking: a modeling study. J Neurosci 1997, 17:91-106.
38. Janahmadi M., Goudarzi I., Kaffashian M.R., Behzadi G., Fathollahi Y., Hajizadeh S. Co-treatment with riluzole, a neuroprotective drug, ameliorates the 3-acetylpyridine-induced neurotoxicity in cerebellar Purkinje neurons of rats: behavioural and electrophysiological evidence. Neurotoxicology 2009, 30:393-402.
39. Kaczmareck L.K., Levitan I.B. What is neuromodulation?. Neuromodulation: the biochemical control of neuronal excitability 1987, 3-17. Oxford University Press, New York, NY. L.K. Kaczmareck, I.B. Levitan (Eds.).
40. Kano M., Ohno-Shosaku T., Hashimotodani Y., Uchigashima M., Watanabe M. Endocannabinoid-mediated control of synaptic transmission. Physiol Rev 2009, 89:309-380.
41. Kiplinger G.F., Manno J.E. Doseresponse relationships to cannabis in human subjects. Pharmacol Rev 1971, 23:339-347.
42. Kreitzer A.C., Regehr W.G. Cerebellar depolarization-induced suppression of inhibition is mediated by endogenous cannabinoids. J Neurosci 2001, 21:RC174.
43. Llinás R., Sugimori M. Electrophysiological properties of in vitro Purkinje cell dendrites in mammalian cerebellar slices. J Physiol 1980, 305:197-213.
44. Lopez L., Chan C.Y., Okada Y.C., Nicholson C. Multimodal characterization of population responses evoked by applied electric field in vitro: extracellular potential, magnetic evoked field, transmembrane potential, and current-source density analysis. J Neurosci 1991, 11:1998-2010.
45. Lozovaya N., Min R., Tsintsadze V., Burnashev N. Dual modulation of CNS voltage-gated calcium channels by cannabinoids: focus on CB1 receptor-independent effects. Cell Calcium 2009, 46:154-162.
46. Mackie K., Lai Y., Westenbroek R., Mitchell R. Cannabinoids activate an inwardly rectifying potassium conductance and inhibit Q-type calcium currents in AtT20 cells transfected with rat brain cannabinoid receptor. J Neurosci 1995, 15:6552-6561.
47. Matsuda L.A. Molecular aspects of cannabinoid receptors. Crit Rev Neurobiol 1997, 11:143-166.
48. Matsukawa H., Wolf A.M., Matsushita S., Joho R.H., Knöpfel T. Motor dysfunction and altered synaptic transmission at the parallel fiber-Purkinje cell synapse in mice lacking potassium channels Kv3.1 and Kv3.3. J Neurosci 2003, 23:7677-7684.
49. McKay B.E., Engbers J.D.T., Mehaffey W.H., Gordon G.R.J., Molineux M.L., Bains J.S., Turner R.W. Climbing fiber discharge regulates cerebellar function by controlling the intrinsic characteristics of Purkinje cell output. J Neurophysiol 2007, 97:2590-2604.
50. + channels enable burst output in rat cerebellar Purkinje cells. Eur J Neurosci 2004, 20:729-739.
51. Mehaffey W.H., Fernandez F.R., Doiron B., Turner R.W. Regulation of somatic firing dynamics by backpropagating dendritic spikes. J Physiol Paris 2008, 102:181-194.
52. Mereu G., Fà M., Ferraro L., Cagiano R., Antonelli T., Tattoli M., Ghiglieri V., Tanganelli S., Gessa G.L., Cuomo V. Prenatal exposure to a cannabinoid agonist produces memory deficits linked to dysfunction in hippocampal long-term potentiation and glutamate release. Proc Natl Acad Sci U S A 2003, 100:4915-4920.
53. Molineux M.L., Fernandez F.R., Mehaffey W.H., Turner R.W. A-type and T-type currents interact to produce a novel spike latency-voltage relationship in cerebellar stellate cells. J Neurosci 2005, 25:10863-10873.
54. Moreno M., Escuredo L., Muñoz R., Rodriguez de Fonseca F., Navarro M. Long-term behavioural and neuroendocrine effects of perinatal activation or blockade of CB1 cannabinoid receptors. Behav Pharmacol 2005, 16:423-430.
55. Navarro M., Rodríguez de Fonseca F., Hernández M.L., Ramos J.A., Fernández-Ruiz J.J. Motor behavior and nigrostriatal dopaminergic activity in adult rats perinatally exposed to cannabinoids. Pharmacol Biochem Behav 1994, 47:47-58.
56. Nemeth B., Ledent C., Freund T.F., Hajos N. CB(1) receptor-dependent and - independent inhibition of excitatory postsynaptic currents in the hippocampus by WIN 55,212-2. Neuropharmacology 2007, 54:51-57.
57. Nguon K., Baxter M.G., Sajdel-Sulkowska E.M. Perinatal exposure to polychlorinated biphenyls differentially affects cerebellar development and motor functions in male and female rat neonates. Cerebellum 2005, 4:112-122.
58. Oz M. Receptor-independent actions of cannabinoids on cell membranes: focus on endocannabinoids. Pharmacol Ther 2006, 111:114-144.
59. Patel S., Hillard C.J. Cannabinoid CB(1) receptor agonists produce cerebellar dysfunction in mice. J Pharmacol Exp Ther 2001, 297:629-637.
60. Pattij T., Wiskerke J., Schoffelmeer A.N. Cannabinoid modulation of executive functions. Eur J Pharmacol 2008, 585:458-463.
61. Perkins E.M., Clarkson Y.L., Sabatier N., Longhurst D.M., Millward C.P., Jack J., Toraiwa J., Watanabe M., Rothstein J.D., Lyndon A.R., Wyllie D.J., Dutia M.B., Jackson M. Loss of beta-III spectrin leads to Purkinje cell dysfunction recapitulating the behavior and neuropathology of spinocerebellar ataxia type 5 in humans. J Neurosci 2010, 30:4857-4867.
62. Pratt K.G., Aizenman C.D. Homeostatic regulation of intrinsic excitability and synaptic transmission in a developing visual circuit. J Neurosci 2007, 27:8268-8277.
63. Ranganathan M., D'Souza D.C. The acute effects of cannabinoids on memory in humans: a review. Psychopharmacology (Berl) 2006, 88:425-444.
64. Rodriguez de Fonseca F., Del Arco I., Martin-Calderon J.L., Gorriti M.A., Navarro M. Role of the endogenous cannabinoid system in the regulation of motor activity. Neurobiol Dis 1998, 5:483-501.
65. Rosenkranz J.A., Johnston D. Dopaminergic regulation of neuronal excitability through modulation of Ih in layer V entorhinal cortex. J Neurosci 2006, 26:3229-3244.
66. Sacco T., Tempia F. A-type potassium currents active at subthreshold potentials in mouse cerebellar Purkinje cells. J Physiol 2002, 543:505-520.
67. Sade H., Muraki K., Ohya S., Hatano N., Imaizumi Y. Activation of large-conductance, Ca2+-activated K+ channels by cannabinoids. Am J Physiol Cell Physiol 2006, 290:C77-C86.
68. + channel deficiency. Proc Natl Acad Sci U S A 2004, 101:9474-9478.
69. Servais L., Hourez R., Bearzatto B., Gall D., Schiffmann S.N., Cheron G. Purkinje cell dysfunction and alteration of long-term synaptic plasticity in fetal alcohol syndrome. Proc Natl Acad Sci U S A 2007, 104:9858-9863.
70. Schweitzer P. Cannabinoids decrease the K1 M-current in hippocampal CA1 neurons. J Neurosci 2000, 20:51-58.
71. Shakkottai V.G., Chou C.H., Oddo S., Sailer C.A., Knaus H.G., Gutman G.A., Barish M.E., LaFerla F.M., Chandy K.G. Enhanced neuronal excitability in the absence of neurodegeneration induces cerebellar ataxia. J Clin Invest 2004, 113:582-590.
72. Shakkottai V.G., Paulson H.L. Physiologic alterations in ataxia: channeling changes into novel therapies. Arch Neurol 2009, 66:1196-1201.
73. + current mediated by the Kv4 channel regulates the generation of action potential in developing cerebellar granule cells. J Neurosci 2000, 20:4145-4155.
74. + currents in cerebellar basket and Purkinje cells: Kv1 and Kv3 channel subfamilies are present in basket cell nerve terminals. J Neurosci 2000, 20:114-122.
75. Steiner H., Bonner T.I., Zimmer A.M., Kitai S.T., Zimmer A. Altered gene expression in striatal projection neurons in CB1 cannabinoid receptor knockout mice. Proc Natl Acad Sci U S A 1999, 96:5786-5790.
76. Stone T.W. Neuropharmacology of quinolinic and kynurenic acids. Pharmacol Rev 1993, 45:309-379.
77. Szabo B., Urbanski M.J., Bisogno T., Di Marzo V., Mendiguren A., Baer W.U., Freiman I. Depolarization-induced retrograde synaptic inhibition in the mouse cerebellar cortex is mediated by 2-arachidonoylglycerol. J Physiol 2006, 577(Pt 1):263-280.
78. Trettel J., Levine E.S. Cannabinoids depress inhibitory synaptic inputs received by layer 2/3 pyramidal neurons of the neocortex. J Neurophysiol 2002, 88:534-539.
79. Tsou K., Brown S., Sanudo-Pena M., Mackie K., Walker J. Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system. Neuroscience 1998, 83:393-411.
80. van Wijk N., Rijntjes E., van de Heijning B.J. Perinatal and chronic hypothyroidism impair behavioural development in male and female rats. Exp Physiol 2008, 93:1199-1209.
81. Walter J.T., Alviña K., Womack M.D., Chevez C., Khodakhah K. Decreases in the precision of Purkinje cell pacemaking cause cerebellar dysfunction and ataxia. Nat Neurosci 2006, 9:389-397.
82. Watase K., Barrett C.F., Miyazaki T., Ishiguro T., Ishikawa K., Hu Y., Unno T., Sun Y., Kasai S., Watanabe M., Gomez C.M., Mizusawa H., Tsien R.W., Zoghbi H.Y. Spinocerebellar ataxia type 6 knock in mice develop a progressive neuronal dysfunction with age-dependent accumulation of mutant CaV2.1 channels. Proc Natl Acad Sci U S A 2008, 105:11987-11992.
83. Williams S.R., Christensen S.R., Stuart G.J., Häusser M. Membrane potential bistability is controlled by the hyperpolarization-activated current IH in rat cerebellar Purkinje neurons in vitro. J Physiol 2002, 539(Pt 2):469-483.
84. Womack M.D., Khodakhah K. Somatic and dendritic small-conductance calcium-activated potassium channels regulate the output of cerebellar Purkinje neurons. J Neurosci 2003, 23:2600-2607.
85. Womack M.D., Khodakhah K. Dendritic control of spontaneous bursting in cerebellar Purkinje cells. J Neurosci 2004, 24:3511-3521.
86. Yoon K.W., Covey D.F., Rothman S.M. Multiple mechanisms of picrotoxin block of GABA-induced currents in rat hippocampal neurons. J Physiol 1993, 464:423-439.
87. + current IA in pyramidal neurons in (rat) primary visual cortex. J Neurosci 2005, 25:9185-9194.
88. Zhang W., Linden D.J. The other side of the engram: experience-driven changes in neuronal intrinsic excitability. Nat Rev Neurosci 2003, 4:885-900.